Spots Global Cancer Trial Database for gemzar
Every month we try and update this database with for gemzar cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma | NCT01983969 | Advanced Cancer... Lymphoma | Azacitidine Vorinostat Gemcitabine Busulfan Melphalan Dexamethasone Caphosol Glutamine Pyridoxine Rituximab | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | NCT00500422 | Solid Tumors | Doxil Gemcitabine Velcade | - | M.D. Anderson Cancer Center | |
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) | NCT00419042 | Non Small Cell ... | TARCEVA Gemzar | 65 Years - | Groupe Francais De Pneumo-Cancerologie | |
| Gemox as First and Second Line Therapy in Unknown Primary Cancer | NCT00353145 | Unknown Primary... | Gemcitabine (Ge... Oxaliplatin Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer | NCT01674556 | Pancreatic Aden... | Gemzar | - | Haukeland University Hospital | |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | NCT00500422 | Solid Tumors | Doxil Gemcitabine Velcade | - | M.D. Anderson Cancer Center | |
| Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer | NCT00521404 | Pancreatic Canc... | CS-1008 (humani... gemcitabine | 18 Years - | Daiichi Sankyo | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer | NCT00769483 | Pancreatic Canc... Pancreatic Aden... | MK-0646 Gemcitabine Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
| A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer | NCT01025570 | Pancreatic Canc... | Gemcitabine, Bo... | 18 Years - | University of California, San Francisco | |
| Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies | NCT01421173 | Lymphoma | Vorinostat Gemcitabine Busulfan Melphalan Stem Cell Infus... Rituximab G-CSF Palifermin Dexamethasone a... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy | NCT00673179 | Osteosarcoma | Doxorubicin Cisplatin Methotrexate Leucovorin Dexrazoxane Ifosfamide Questionnaire Gemcitabine Sargramostim Surgery Mesna | 5 Years - 40 Years | M.D. Anderson Cancer Center | |
| Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy | NCT01938716 | Pancreatic Canc... | Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Gemcitabine and Dasatinib in Advanced Solid Tumors | NCT00429234 | Advanced Cancer Solid Tumors | Dasatinib Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer | NCT00388154 | Endometrial Can... | Gemcitabine Cisplatin | - | M.D. Anderson Cancer Center | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer | NCT00270907 | Metastatic Brea... Breast Cancer | CT-2103 Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer | NCT00769483 | Pancreatic Canc... Pancreatic Aden... | MK-0646 Gemcitabine Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | NCT00500422 | Solid Tumors | Doxil Gemcitabine Velcade | - | M.D. Anderson Cancer Center | |
| Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) | NCT00419042 | Non Small Cell ... | TARCEVA Gemzar | 65 Years - | Groupe Francais De Pneumo-Cancerologie | |
| Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer | NCT00894504 | Metastatic Brea... | Panitumumab Carboplatin Gemcitabine | 18 Years - | SCRI Development Innovations, LLC | |
| Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer | NCT00113256 | Pancreatic Canc... | Rubitecan | 18 Years - | Astex Pharmaceuticals, Inc. | |
| Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma | NCT02114502 | Myeloma | Carfilzomib SAHA Gemcitabine Busulfan Melphalan Stem Cell Trans... Palifermin Dexamethasone Caphosol Glutamine Pyridoxine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| PP-Gemcitabine & External Beam Radiation-Sarcomas | NCT02046304 | Sarcoma | Gemcitabine Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer | NCT02769832 | Small Cell Lung... | Nab-paclitaxel Gemcitabine | 18 Years - 99 Years | University of Iowa | |
| Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma | NCT02701673 | Lymphoma | Busulfan Caphosol Glutamine Pyridoxine Belinostat Azacitidine Gemcitabine Melphalan Stem Cell Trans... | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | NCT00832637 | Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi... | Cisplatin Erlotinib Gemcitabine | 18 Years - | New Mexico Cancer Care Alliance | |
| Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer | NCT02581501 | Pancreatic Canc... | GAX - Gemcitabi... | 18 Years - | Stamford Hospital | |
| Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer | NCT02581501 | Pancreatic Canc... | GAX - Gemcitabi... | 18 Years - | Stamford Hospital | |
| Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas | NCT01276613 | Pancreatic Canc... | Gemcitabine Losartan | 18 Years - | M.D. Anderson Cancer Center | |
| Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer | NCT00894504 | Metastatic Brea... | Panitumumab Carboplatin Gemcitabine | 18 Years - | SCRI Development Innovations, LLC | |
| Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer | NCT00193206 | Breast Cancer | Gemcitabine Epirubicin Albumin-bound P... | 18 Years - | SCRI Development Innovations, LLC | |
| Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas | NCT01276613 | Pancreatic Canc... | Gemcitabine Losartan | 18 Years - | M.D. Anderson Cancer Center | |
| ZN-c3 + Gemcitabine in Pancreatic Cancer | NCT06015659 | Advanced Pancre... Pancreatic Canc... Pancreatic Duct... | Zentalis Gemzar | 18 Years - | Dana-Farber Cancer Institute | |
| Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma | NCT02701673 | Lymphoma | Busulfan Caphosol Glutamine Pyridoxine Belinostat Azacitidine Gemcitabine Melphalan Stem Cell Trans... | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Acelarin First Line Randomised Pancreatic Study | NCT03610100 | Pancreatic Acin... Pancreatic Neop... | Acelarin Gemcitabine | 18 Years - | The Clatterbridge Cancer Centre NHS Foundation Trust | |
| A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer | NCT01025570 | Pancreatic Canc... | Gemcitabine, Bo... | 18 Years - | University of California, San Francisco | |
| Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer | NCT00193206 | Breast Cancer | Gemcitabine Epirubicin Albumin-bound P... | 18 Years - | SCRI Development Innovations, LLC | |
| PP-Gemcitabine & External Beam Radiation-Sarcomas | NCT02046304 | Sarcoma | Gemcitabine Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer | NCT00894504 | Metastatic Brea... | Panitumumab Carboplatin Gemcitabine | 18 Years - | SCRI Development Innovations, LLC | |
| Pemetrexed Plus Gemcitabine in Renal Cell Cancer | NCT00491075 | Renal Cell Carc... | Pemetrexed Gemcitabine | - | M.D. Anderson Cancer Center | |
| A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour | NCT00778128 | Solid Tumors | CP-4126 Gemcitabine | 18 Years - | Clavis Pharma | |
| Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma | NCT01554410 | Cervical Carcin... | Intensity Modul... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| Gemcitabine and Dasatinib in Advanced Solid Tumors | NCT00429234 | Advanced Cancer Solid Tumors | Dasatinib Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies | NCT00410982 | Leukemia Lymphoma Myeloma | Busulfan Gemcitabine Melphalan Hematopoietic C... Rituximab for P... Palifermin | 18 Years - 69 Years | M.D. Anderson Cancer Center | |
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors | NCT00479128 | Solid Tumor Urethral Cancer | Bortezomib Gemcitabine Doxorubicin | - | M.D. Anderson Cancer Center | |
| A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer | NCT06278493 | Pancreatic Canc... | AL2846 capsules Gemzar | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer | NCT02581501 | Pancreatic Canc... | GAX - Gemcitabi... | 18 Years - | Stamford Hospital | |
| A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | NCT00035035 | Pancreatic Neop... Metastases, Neo... | GEMZAR ALIMTA | 18 Years - | Eli Lilly and Company | |
| A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer | NCT02231723 | Metastatic Panc... | BBI608 Nab-paclitaxel Gemcitabine Oxaliplatin Leucovorin Irinotecan Fluorouracil MM-398 | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) | NCT02905578 | Pancreatic Neop... Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... Adenocarcinoma | Gemcitabine nab-paclitaxel Pharmacological... | 18 Years - | University of Iowa | |
| Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer | NCT00521404 | Pancreatic Canc... | CS-1008 (humani... gemcitabine | 18 Years - | Daiichi Sankyo | |
| Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy | NCT01938716 | Pancreatic Canc... | Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer | NCT01547260 | Pancreatic Carc... Pancreatic Duct... | Gemzar Revlimid | 19 Years - | Karolinska University Hospital | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer | NCT00894504 | Metastatic Brea... | Panitumumab Carboplatin Gemcitabine | 18 Years - | SCRI Development Innovations, LLC | |
| Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) | NCT01964430 | Pancreatic Neop... Digestive Syste... Neoplasms by Si... Neoplasms Endocrine Gland... Pancreatic Dise... Digestive Syste... Endocrine Syste... Gemcitabine Antimetabolites... | nab-Paclitaxel Gemcitabine | 18 Years - | Celgene | |
| High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma | NCT01237951 | Myeloma | Palifermin Dexamethasone Gemcitabine Busulfan Melphalan Stem Cell Trans... G-CSF | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) | NCT01881230 | Breast Tumor Breast Cancer Cancer of the B... Estrogen Recept... HER2- Negative ... Progesterone Re... Recurrent Breas... Stage IV Breast... Triple-negative... Triple-negative... Metastatic Brea... | nab-Paclitaxel Carboplatin Gemcitabine | 18 Years - | Celgene | |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype | NCT02589145 | Lymphoma | Lenalidomide Vorinostat Gemcitabine Busulfan Melphalan Rituximab Dexamethasone Caphosol Glutamine Pyridoxine Enoxaparin Stem Cell Trans... Palifermin | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease | NCT00385788 | Hodgkin's Disea... | Gemcitabine Fludarabine Melphalan Antithymocyte G... Allogeneic Stem... Tacrolimus Filgrastim (G-C... Methotrexate | - 65 Years | M.D. Anderson Cancer Center | |
| Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer | NCT02154737 | Pancreatic Canc... | Gemcitabine Erlotinib | 18 Years - | University of California, San Diego |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
